Japan-based Takeda Biopharmaceuticals on Monday announced that India’s drug regulator has granted market authorisation to its anti-dengue vaccine QDENGA, making it the first dengue vaccine approved for use in the country.
India gets first dengue vaccine as DCGI approves Takeda’s QDENGA
